愿景：JAMA Oncology致力于發(fā)表有影響力的原創(chuàng)研究、意見和評論，促進腫瘤學和改善癌癥患者的臨床護理。使命：JAMA腫瘤學是全球腫瘤學領域的科學家、臨床醫(yī)生和培訓生的權威期刊。我們原創(chuàng)的、創(chuàng)新的、及時的科學和教育內容為讀者提供了對癌癥發(fā)病機制和最新治療進展的更深入的了解。JAMA腫瘤學旨在有效地將重要臨床研究成果、重大科學突破、可操作的發(fā)現(xiàn)和最先進的治療方法傳達給腫瘤學社區(qū)。我們的目標是，新知識的成功交流最終將轉化為癌癥患者和幸存者的臨床利益。編輯團隊。《美國醫(yī)學會腫瘤雜志》的創(chuàng)始主編是瑪麗·l·迪斯(Nora)，醫(yī)學博士。迪斯博士是華盛頓大學(UW)的醫(yī)學教授、病理學和婦產科副教授，弗雷德·哈欽森癌癥研究中心的成員。她是華盛頓大學醫(yī)學院轉化科學副院長，華盛頓大學轉化醫(yī)學和婦女健康中心主任，以及華盛頓大學轉化健康科學研究所主任。迪斯博士是乳腺癌和卵巢癌、免疫治療和轉化研究方面的專家。有關《華爾街日報》編輯和編輯委員會的完整列表，請參見下面的編輯和出版商鏈接。期刊出版及編輯資訊。JAMA Oncology是一份經同行評審的國際期刊，每周四在網上出版，每月出版一期。錄取率為21%。初始編輯決定的時間為1天不審核，35天有審核。所有的文章都是先在網上發(fā)表的，平均接受時間為71天。所有研究論文出版后12個月免費在線閱讀。所有文章在出版當天都可以免費訪問JAMA網絡閱讀器。JAMA Oncology也為合格手稿的作者提供了開放存取的選擇。有關詳細信息，請參閱作者說明。此外，通過世界衛(wèi)生組織的HINARI項目，該雜志向發(fā)展中國家的機構免費提供或幾乎免費提供。感興趣的話題。《美國醫(yī)學會腫瘤學》發(fā)表關于醫(yī)學、放射、外科腫瘤學及其分支學科的所有方面的論文，包括以下主題:乳腺癌癌癥生物標記物癌癥遺傳學癌癥相關的并發(fā)癥癌癥治療骨髓/干細胞移植化療新的治療方法治療相關的并發(fā)癥臨床指南臨床試驗診斷和分期藥物發(fā)現(xiàn)內分泌系統(tǒng)癌癥流行病學，癌癥預防和控制胃腸道癌癥膽道癌結腸癌食道癌胃癌肝癌癥胰腺癌直腸癌泌尿生殖器的癌癥前列腺癌腎癌泌尿道腫瘤老年腫瘤學婦科癌癥子宮頸癌子宮內膜癌卵巢癌頭頸癌血液惡性腫瘤成像免疫療法肺癌Neuro-oncology腦癌中樞神經系統(tǒng)癌姑息治療癌癥的支持性護理疼痛控制兒科癌癥質量和衛(wèi)生服務研究經濟學衛(wèi)生政策放射腫瘤學肉瘤皮膚癌黑素瘤軟組織腫瘤平移腫瘤學未知的原發(fā)部位和罕見的癌癥JAMA腫瘤學ISSN 2374 - 2437(印刷)ISSN 2374 - 2445(在線)2016年4月更新

Vision. JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.Mission. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers.JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.Editorial Team. The founding Editor in Chief of JAMA Oncology is Mary L. (Nora) Disis, MD. Dr Disis is a Professor of Medicine and Adjunct Professor of Pathology and Obstetrics and Gynecology at the University of Washington (UW), and a Member of the Fred Hutchinson Cancer Research Center. She is the Associate Dean for Translational Science in the UW School of Medicine, Director of the UW Center for Translational Medicine and Women''''''''s Health, and Director, UW Institute for Translational Health Sciences. Dr Disis is an expert in breast and ovarian cancer, immunotherapy, and translational research. For a complete listing of the journal’s Editors and Editorial Board, see link to Editors and Publishers below.Journal Publication and Editorial Information. JAMA Oncology is an international peer-reviewed journal that is published online each Thursday and in a print/online issue every month. The acceptance rate is 21%. Time to initial editorial decision is 1 day without review and 35 days with review. All articles are published Online First within a median of 71 days of acceptance. All research articles are made free access online 12 months after publication. All articles are made free access on The JAMA Network Reader on the day of publication. JAMA Oncology also has an open access option for authors of eligible manuscripts. See Instructions for Authors for details. In addition, the journal is made freely available or nearly so to institutions in developing countries through the World Health Organization''''''''s HINARI program.Topics of Interest. JAMA Oncology publishes papers on all aspects medical, radiation, and surgical oncology and its subspecialties, including the following Topics: Breast Cancer Cancer Biomarkers Cancer Genetics Cancer-Related Complications Cancer Therapy and Treatment Bone Marrow/Stem Cell Transplantation Chemotherapy Novel Therapies Treatment-Related Complications Clinical Guidelines Clinical Trials Diagnosis and Staging Drug Discovery Endocrine System Cancer Epidemiology, Cancer Prevention, and Control Gastrointestinal Cancer Biliary Cancer Colon Cancer Esophageal Cancer Gastric Cancer Hepatic Cancer Pancreatic Cancer Rectal Cancer Genitourinary Cancer Prostate Cancer Renal Cancer Urinary Tract Cancer Geriatric OncologyGynecologic CancerCervical CancerEndometrial CancerOvarian CancerHead & Neck CancerHematologic MalignanciesImagingImmunotherapyLung CancerNeuro-oncologyBrain CancerCentral Nervous System CancerPalliative CareCancer Supportive CarePain ControlPediatric CancerQuality and Health Services ResearchEconomicsHealth PolicyRadiation OncologySarcomasSkin CancerMelanomaSoft-Tissue TumorsTranslational OncologyUnknown Primary Site and Rare CancersJAMA OncologyISSN 2374-2437 (Print)ISSN 2374-2445 (Online)Updated April 2016